Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Retained Earnings

-$470.33M

Quarterly · Period ending: · USD

LCTX logo

LCTX Retained Earnings

Latest reported-$470.33M
LCTX Quarterly Retained Earnings (-$700.00K → -$470.33M)
High-resolution chart · PNG

LCTX retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-29,208,007
-28,087,983
-27,136,244
-26,085,883
-24,860,928
-23,531,167
-22,211,220
-20,800,000
-18,500,000
-17,500,000
-15,800,000
-14,600,000
-13,900,000
-12,800,000
-12,200,000
-11,200,000
-10,100,000
-8,100,000
-8,800,000
-8,100,000
-6,500,000
-6,100,000
-5,400,000
-3,700,000
-4,200,000
-3,700,000
-3,300,000
-2,900,000
-2,200,000
-2,200,000
-1,900,000
-1,600,000
-1,300,000
-1,000,000
-700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.